openPR Logo
Press release

Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Market Analysis Top Companies like therapeutics and diagnostics market are Eli Lilly and Company, AbbVie Inc., VIVUS Inc., Mayoly Spindler, ALLERGAN, Nordmark Arzneimittel GmbH &

04-30-2019 09:51 AM CET | Health & Medicine

Press release from: Data Bridge Market Research

Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Market

Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Market

The Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics market report contains market insights and analysis for ABC industry which are backed up by SWOT analysis. In this report, several aspects about the market research and analysis for the ABC industry have been underlined. This market research report acts as a great support to any size of business whether it is large, medium or small. The precise and state-of-the-art information provided via this report helps businesses get aware about the types of consumers, consumer’s demands and preferences, their point of view about the product, their buying intentions, their response to particular product, and their varying tastes about the specific product already existing in the market.

Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Market By Type (Therapeutics, Diagnostics), Therapeutic Drugs (Creon, Zenpep, Pancreaze, Ultresa, Viokace, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026

For In depth Information Get Free Sample Copy of this Report@ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-exocrine-pancreatic-insufficiency-epi-therapeutics-and-diagnostics-market

Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Market is expected to rise from its initial estimated value of USD 3.96 billion to a projected value of USD 7.09 billion by 2026, registering a CAGR of 7.57% in the forecast period of 2019-2026. This rise in market value can be attributed to the large number of therapies and drugs in the pipeline of major pharmaceutical companies currently present in the market.

Market Definition:

Exocrine pancreatic insufficiency is a disorder which causes the pancreas to behave improperly resulting in the lack of generation of digestive enzymes required for the proper digestion of food. It is majorly caused in humans suffering from cystic fibrosis. The therapeutics currently prevalent in the market includes lifestyle changes, management of nutritional intake enzyme replacement. The diagnostics procedures include testing the blood sample, various diagnostic imaging procedures and others.

Competitive Analysis:

Global exocrine pancreatic insufficiency (EPI) therapeutics and diagnostics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of exocrine pancreatic insufficiency (EPI) therapeutics and diagnostics market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Competitors:

Few of the major competitors currently working in the exocrine pancreatic insufficiency (EPI) therapeutics and diagnostics market are Eli Lilly and Company; AbbVie Inc.; VIVUS Inc.; Mayoly Spindler; ALLERGAN; Nordmark Arzneimittel GmbH & Co. KG; Janssen Global Services, LLC; PDL BioPHARMA; Cilian AG; Digestive Care, Inc.; Anthera and AzurRx.

Market Drivers

• Increase in the prevalence of diabetes globally which is one of the major factors behind the generation of cystic fibrosis which ultimately causes EPI; this factor is expected to drive the market growth

• Increasing expenditure incurred on healthcare and development of healthcare infrastructure along with increasing prevalence of
the disorders are expected to positively affect the market growth

Market Restraints

• Presence of strict regulations regarding the approval and commercialization of therapies across the various regions is expected to restrain the market growth

• Lack of advancements in technology and innovations for the treatment of disorders is expected to restrain the market growth

Key Developments in the Market:

• In May 2018, VIVUS Inc. announced that, they had agreed to acquire the product rights for “PANCREAZE (pancrelipase)” from Janssen Global Services, LLC for the United States and Canada region. This acquisition will significantly improve the financial standpoint of the company and will improve the product offerings for the gastrointestinal disorders market.

• In December 2016, ALLERGAN announced that, they had received a positive opinion for marketing authorization of “ENZEPI®
(pancrelipase)” in the European region from Committee for Medicinal Products for Human Use (CHMP). The product is a therapeutic PERT (Pancreatic Enzyme Replacement Therapy) for patients suffering from Exocrine Pancreatic Insufficiency (EPI). This positive opinion is a big step in bringing this therapy into the market for the European region.

Reasons to Purchase this Report

• Current and future of global exocrine pancreatic insufficiency (EPI) therapeutics and diagnostics market outlook in the developed and emerging markets

• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period

• Regions/Countries that are expected to witness the fastest growth rates during the forecast period

• The latest developments, market shares, and strategies that are employed by the major market players

Inquire about this report from our expert’s @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-exocrine-
pancreatic-insufficiency-epi-therapeutics-and-diagnostics-market

Segmentation:

• By Type
o Therapeutics
o Nutritional Management
o Pancreatic Enzyme Replacement Therapy (PERT)
o Lifestyle Modification
o Diagnostics
o Blood Tests
o Magnetic Resonance Imaging (MRI)
o Computed Tomography (CT) Scanning
o Endoscopic Ultra-Sonography (EUS)
o Others

• By Therapeutic Drugs

o Creon
o Zenpep
o Pancreaze
o Ultresa
o Viokace
o Others

Customization of the Report:

• All segmentation provided above in this report is represented at country level

• All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Market Analysis Top Companies like therapeutics and diagnostics market are Eli Lilly and Company, AbbVie Inc., VIVUS Inc., Mayoly Spindler, ALLERGAN, Nordmark Arzneimittel GmbH & here

News-ID: 1723200 • Views: 854

More Releases from Data Bridge Market Research

Cervical Cancer Drug Market Sees Huge Growth by 2026 | Johnson & Johnson Service …
Global cervical cancer drug market is growing at a substantial CAGR in the forecast period of 2019-2026. The report contains data of the base year 2018 and historic year 2017. This rise in market value can be attributed to the high prevalence of cancer, rise in incidence of HIV in women, unprotected/unsafe sex, and lack of knowledge regarding diagnostic tests for prevention of invasive cancer. Request Sample of Global Cervical Cancer
Hemostats Market: The Next Booming Segment in the World | Arch Therapeutics, Inc …
Global Hemostats Market By Product Type (Thrombin Based, Combination, Oxidized Regenerated Cellulose Based, Gelatin Based, Collagen Based Hemostat), Formulation (Matrix & Gel Hemostats , Sheet & Pad Hemostats, Sponge Hemostats, Powder Hemostats), Application (Orthopedic, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery), Indication (Wound Closure, Surgery), End-User (Hospitals, Clinics, Ambulatory Centers, Community Healthcare, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends
Rose Oil Market Size, Industry Share, Growth, Trends Analysis 2020, Statistics, …
Rose Oil Market is expected to gain market growth in the forecast period of 2020 to 2027. Data bridge market research analyses the market to account USD 575.97 mill ion by 2027 with the CAGR of 8.40% in the above-mentioned forecast period. The market player's focus on their research and development efforts to introduce new and innovative rose oil products, as demand for rose oil has increased due to its
Corneal Ulcer Treatment Marketto Set New Growth Cycle| Alembic Pharmaceuticals …
Corneal ulcer treatment marketis expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing at a healthy CAGR in the above-mentioned research forecast period. Rising prevalence of the eyes diseases worldwide and emerging markets are the factors responsible for the growth of this market. Get Sample Copy of This Research Report athttps://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-corneal-ulcer-treatment-market The major players covered in the corneal ulcer

All 5 Releases


More Releases for EPI

Exocrine Pancreatic Insufficiency (EPI) Therapeutics- Pipeline Analysis
Exocrine pancreatic insufficiency (EPI) is the inability of pancreas to produce enough enzymes for the proper breakdown and absorption of nutrients. The common causes of EPI are damage to pancreas, inflammation of pancreas, pancreatic surgery, and inherited disorders like Crohn’s disease and celiac disease. Download the sample report at: https://www.pharmaproff.com/request-sample/1024 Some symptoms observed during EPI are pain or tenderness in belly, bad-smelling bowel movements, gas, diarrhea and feeling of fullness. EPI
Exocrine Pancreatic Insufficiency (EPI) Therapeutics Market Opportunity Analysis …
Exocrine pancreatic insufficiency (EPI) is a condition associated with deficiency of exocrine pancreatic enzymes that results in the inability to digest food or maldigestion. EPI may be associated with certain diseases and conditions that affect the pancreas such as cystic fibrosis, chronic pancreatitis, Shwachman–Diamond syndrome, and others. Chronic pancreatitis (CP) is the most common cause of EPI in adults that is followed by cystic fibrosis (CF). CF is an inherited
Global Epi Wafer Market 2018 - Nichia, EpiWorks, Norstel, OMMIC
Eminent Market, recently published a detailed market research study focused on the "Epi Wafer Market" across the global, regional and country level. The report provides 360° analysis of "Epi Wafer Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Epi Wafer industry, and estimates the future trend of Epi Wafer market on
United States Epi Wafer Market: Moving Towards a Brighter Future
Qyresearchreports include new market research report Epi Wafer to its huge collection of research reports. The report here assembles exchange points of view having a place with the United states Epi Wafer market which verbalizes the present-day information and future exposures with reference to the dynamic forces at play. The prime explanation for the examination report is to offer the endorser with a wide outline and make open the satisfying substances
Epi Wafer Market 2017 - GlobalWafers, Nichia, EpiWorks
Apex Research, recently published a detailed market research study focused on the "Epi Wafer Market" across the global, regional and country level. The report provides 360° analysis of "Epi Wafer Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Epi Wafer industry, and estimates the future trend of Epi Wafer market on
Epitaxial (Epi) Wafer Market 2017- ASM International, EpiWorks, Jenoptik
Marketreports.biz, recently published a detailed market research study focused on the "Epitaxial (Epi) Wafer Market" across the global, regional and country level. The report provides 360° analysis of "Epitaxial (Epi) Wafer Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Epitaxial (Epi) Wafer industry, and estimates the future trend of Epitaxial